Martin Shkreli: I Made $60M When My Pharma Company Went Public (Part 5)

Watch the full interview now as a VladTV Youtube Member – https://www.youtube.com/vladtv/join

Part 6: https://youtu.be/knNBEcf4i04
Part 4: https://youtu.be/foKqsf31360
Part 1: https://youtu.be/pun5ZxRHa9U
——–
Martin Shkreli discussed his financial success when his pharmaceutical company, Retrophin, went public. Shkreli shared an intriguing backstory into the company. Initially a private entity, Retrophin experienced overwhelming investor interest, with demand far exceeding their $40 million target during their Nasdaq IPO. Shkreli recounted a critical moment when Vivek demanded every dollar of his $15 million investment, citing his early faith in Shkreli’s vision. Despite fierce competition from other investors, Shkreli honored Vivek’s request, a decision he reminisced about with admiration. Retrophin’s stock surged from its initial public price of around $3 to as high as $28, contributing to Shkreli’s fortune of approximately $60 million. Despite this financial success, Shkreli’s tenure at the helm was cut short.